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Abstract: 
Microglia are critical in the pathogenesis of neuropathic pain. In this study we 
investigated the role of microvesicles (MVs) in neuropathic pain induced by spinal 
nerve ligation (SNL) in rats. First, we found that MVs shed from microglia were 
increased in the cerebrospinal fluid and dorsal horn of the spinal cord after SNL. Next, 
MVs significantly reduced paw withdrawal threshold (PWT) and paw withdrawal 
latency (PWL). In addition, the P2X7-p38 pathway was related to the bleb of MVs 
after SNL. Interleukin (IL)-1β was found to be significantly upregulated in the 
package of MVs, and PWT and PWL increased following inhibition with 
shRNA-IL-1β. Finally, the amplitude and frequency of spontaneous excitatory 
postsynaptic currents increased following stimulation with MVs. Our results indicate 
that the P2X7-p38 pathway is closely correlated with the shedding of MVs from 
microglia in neuropathic pain, and MVs had a significant effect on neuropathic pain 
by participating in the interaction between microglia and neurons. 
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Introduction: 
Neuropathic pain is a chronic pain caused by a lesion or disease of the somatosensory 
nervous system and characterized by hyperalgesia and allodynia [1, 2]. It is an 
unpleasant sensory consequence of neuronal activities in specific nociceptive 
pathways that is triggered by noxious stimuli, inflammation, or damage to the nervous 
system [3]. It is now clear that in addition to neurons playing an important role in the 
maintenance of common clinical pain, immune and glia cells are also involved in the 
pathological changes following nerve injury [4]. However, since various pain 
receptors are involved together with sensitization of sensory neurons, as well as the 
role of soluble mediators released from non-neuronal cells such as macrophages and 
mast cells, it is still difficult to understand the complicated spatial and temporal scale 
of pain development and neuronal disease progression [3, 5]. Thus, neuropathic pain 
remains an important large clinical and social problem since there is insufficient pain 
relief from current treatments. 
The pro-inflammatory cytokines interleukin (IL)-1β, IL6, IL12, interferon-γ, and 
tumor necrosis factor (TNF), have been demonstrated to contribute to axonal damage 
[6]. In addition, they also modulate spontaneous nociceptor activity and stimulus 
sensitivity [7]. It has been reported that a delayed immune response to nerve injury at 
the lesion site occurs with an upregulation of IL-1β and TNF-α in macrophages and 
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Schwann cells, indicating a significant effect of inflammatory reactions on peripheral 
neuropathic pain [8]. 
In pathological conditions, ATP, one of the most powerful mediators, activates 
microglia via P2X7 receptors, resulting in increased release of cytokines, including 
IL-1β, -6, -10, TNF-α and transforming growth factor-β. Direct modulation of dorsal 
horn neuron activity driven by these cytokines plays an important role in the 
development of neuropathic pain [9].  
Recently, extracellular vesicles, including exosomes and plasma membrane-derived 
microvesicles (MVs), also called microparticles, have gained increasing attention as 
efficient vehicles for the release of signaling molecules in cell communication and 
information exchange, including the interaction between glia and neurons. This 
information exchange promotes neuronal survival, the immune response mediated by 
microglaia, and synapse assembly and plasticity [10]. In Alzheimer's disease (AD), 
microglia-derived MVs aggregates amyloid-β into neurotoxic forms participating in 
AD degeneration [11]. It has been demonstrated that the budding and shedding of 
microparticles can be triggered by stimulation of the P2X7 ATP receptor that activates 
the p38 MAPK cascade through src kinase-mediated phosphorylation [12]. In contrast, 
phosphorylated p38 triggers plasma-membrane pore formation and mobilization of 
acid-sphingomyelinases, which further alters membrane fluidity, leading to 
plasma-membrane budding and shedding. IL-1β is released into the extracellular 
environment through shed microparticles to participate in the communication between 
microglial and neuronal cells [12].  
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To date, MVs, an important membrane-enclosed compartment of cells, have not been 
studied in relation to neuropathic pain. Thus, investigating the effect and molecular 
mechanism of microvesicles occurring in neuropathic pain may allow the design of 
appropriate tissue- and cell-targeted approaches to treat neuropathic pain. In this study, 
we have investigated the role of microvesicles in neuropathic pain induced by spinal 
nerve ligation (SNL) in rats and its participation in the interaction between microglia 
and neurons via pro-inflammatory cytokines and neurotransmission. 
 
Materials and methods: 
Animals. Sprague Dawley rats (200g) were purchased from the Laboratory Animal 
Center of the Second Military Medical University. Rats were randomly assigned to 
standard cages, with three to four animals per cage. Rats were housed in the 
Laboratory Animal Center of the Second Military Medical University, 12:12 hour 
light/dark cycle with adequate food and water. The rats were placed in the 
experimental room 24h before behavioral test for acclimatization. All animal 
experiments were reviewed and approved by the Institutional Animal Care and Use 
Committee of the Second Military Medical University and conformed to the 
American Physiological Society's Guiding Principles in the Care and Use of Animals. 
Six rats per group were used for behavioral tests. All efforts were made to minimize 
animal suffering.  
 
Spinal nerve ligation. Behavioral tests were performed before surgery to establish a 
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baseline. Neuropathic pain was induced by ligating the L5 spinal nerve as in previous 
research [13]. With sodium pentobarbital anesthesia (50mg/kg body weight, i.p.), the 
rat was barbered at the lower back and the skin was sterilized with 0.5% 
chlorhexidine and covered with clean gauze. Using sterilized operating instruments, 
the left paraspinal muscles were separated from the spinous processes at the L5-6 
levels and the L6 transverse process was carefully removed. The L5 spinal nerve was 
isolated and tightly ligated with 3-0 silk threads. The wound was washed with 5 ml of 
distilled saline and sutured with 3-0 silk threads. In sham-operated rats, the left L5 
spinal nerve was isolated without ligation treatment.  
 
Intrathecal catheter. Implantation of intrathecal cannula was performed following 
the method described in a previous study [14]. Under anaesthesia with sodium 
pentobarbital, the L4 - L5 spinal processes were exposed and the muscles beside the 
processes were isolated bluntly. Then a PE-10 polyethylene tubing was inserted into 
the cavum subarachnoidale through the interval between L4 and L5 vertebrate, 
approximately 1 cm until the tip of the tubing reached to the lumbar cisterna. The 
outer part of the tubing was fixed onto the muscle of the lumbar and the skin of the 
head. The fluid within the tubing was about 10 μL. A small volume of lidocaine, 
approximately 10 μL, was administered in the tubing followed by 10 μL artificial 
cerebrospinal fluid (CSF) and the rat exhibited motor dysfunction, which indicated the 
successful implantation of the intrathecal catheter. In the experimental group, a single 
10 μL volume of FTY720 (1mM) or MVs (104 per rat) was injected into the SNL7d 
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rat or the naive rat, respectively, followed by a 10 μL dose of artificial CSF. However, 
in the control group, 20 μL of artificial CSF was administrated directly. 
 
Cerebrospinal fluid extraction. Rats were anesthetized with sodium pentobarbital 
(50 mg/kg body weight, i.p.) and fixed on the stereotaxic instrument. The skin was 
incised at the midline of occipitalia and the muscles were dissected bluntly. The 
foramina magnum was exposed and CSF was extracted with a 100 μL microinjector. 
Approximately 100 μL volume of CSF was extracted from each rat, the CSF was put 
in a 1.5 ml epoxy epoxide (EP) tube containing 1 μL of phenylmethanesulfonyl 
fluoride (PMSF). All EP tubes were placed on ice to reduce CSF temperature and 
therefore decrease MVs rupture.   
 
MV isolation: The MVs were isolated by differential centrifugations according to a 
previous report [15]. Briefly, CSF or the medium from cultured N9 microglia was 
subjected to differential centrifugations: firstly, 5 minutes at 800g to remove cells and 
then 5 minutes at 4500 g to discard large debris. Then the supernatant was spun down 
at 20,000 g for 1 h at 4 °C to provide a pellet enriched in MVs. 
 
siRNA targeting rat P2X7R mRNA: P2X7 siRNA was synthesized according to the 
four sense sequences shown in a previous study [16]. (1) 
GUACAGUGGCUUCAAGU 
AU; (2) GGAUGGACCCACAAAGUAA; (3) UUACAGAGGUGGCAGUU CA; (4) 
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GAACGAUGUCUUUCAGUAU. SiGENOME RISC-Free control-siRNA was used 
as non-targeting control. 
 
Cell culture and transfection of IL-1β-shRNA using lentiviral infection: The N9 
microglia cell line was obtained from the Department of Neurobiology, Second 
Military Medical University. N9 cells were cultured in Dulbecco's Modified Eagle 
Media: Nutrient Mixture (DMEM/F12) with 10% fetal calf serum (Gibco, Australia), 
100U/mL penicillin and 100 μg/mL streptomycin. The temperature was 37°C and the 
concentration of CO2 was 5%. The medium was changed every 2-3 days and cells 
passaged every 4-5 days. When the number of N9 cells in a T25 bottle was 
approximately 1×106, the medium was removed and the cells were treated with 
endotoxin lipopolysaccharide (LPS; 10μg/mL) for 2h, as described previously [17]. 
Cells were washed twice with PBS, and then treated with 2'(3')-O-(4-benzoylbenzoyl) 
ATP (BzATP; 300 μΜ) in serum-free medium for 30 minutes. Thereafter, the medium 
was collected to isolate MVs as described above.   
For transfection of IL-1β-shRNA, N9 cell line was grown in a 12-well plate and 
infected at almost 50% confluence with lentivirus vectors for IL-1β-shRNA or 
scrambled-shRNA. After a 12-hour treatment, the cultured medium was changed to a 
conditional medium, and the microglia were further cultured for 48 h and then treated 
with BzATP (300 μΜ) in serum-free medium for 30 minutes, as described above. 
 
Behavioral tests. The behavioral tests for mechanical allodynia and thermal 
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hyperalgesia were carried out on rats 1 day prior to surgery and 1, 3, 5, 7, 10, and 14 
days after surgery until sacrifice. Mechanical allodynia was assessed by measuring the 
paw withdraw threshold (PWT) in response to probing using von Frey monofilaments 
(Stoelting, Wood Dale, IL, USA). Briefly, the rat was placed in a plastic cage, which 
was elevated on a mesh screen. Each rat was allowed to acclimate for 30 minutes 
prior to testing. Calibrated filaments, ranging from 1g to 15g, were applied to the 
plantar surface of the left hind paw. Each filament was applied over five sessions, two 
times per session, at least 5 minutes between two sessions and 5 seconds between the 
two applications. The minimum of the filament value causing five positive responses 
(paw withdrawal or licking) in ten tests was taken as the PWT. Thermal hyperalgesia 
was assessed by testing the paw withdrawal latency (PWL) using the plantar test 
(7370, UGO BASILE, Italy). Specifically, the rat was placed beneath the same plastic 
cage used for the mechanical allodynia test, but this time upon an elevated glass floor. 
With the rat standing relatively still, a radiant heat source beneath the glass floor was 
aimed at the plantar surface of the hind paw. The withdrawal latency was measured to 
the nearest 0.1 s. Prior to assessment of heat hyperalgesia, the intensity of the radiant 
heat source was adjusted to yield a mean baseline latency of approximately 11s from 
six naive rats with the cutoff automatically set at 22.5 s to avoid tissue damage. The 
hind paws were tested alternately with at least 5 minutes between consecutive tests. 
Three latencies were taken for each hind paw in each test session. The three latencies 
per side were averaged and a difference score was computed by subtracting the 
average latency of the paw on the contralateral side from that of the ipsilateral side. 
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Negative difference scores indicated a hyperalgesic response on the ipsilateral side. 
 
Electrophysiological recording. Spinal cord slices were prepared from 
Sprague-Dawley rats (120 g – 150 g). In brief, the adult rats were deeply anesthetized 
with sevoflurane, and then the lumbosacral enlargement of the spinal cord was 
exposed. The spinal cord was removed immediately and placed in pre-chilled artificial 
CSF saturated with 95% O2 and 5% CO2. It was mounted on a vibratome and a 
400μm thick transverse slice was cut from the lumbar segment. The slice was placed 
in an incubation slot, and the incubation buffer was heated to a temperature of 37C. 
The slice was incubated for 1 hour and then electrophysiological recording was 
performed. 
For recording spontaneous excitatory postsynaptic currents (sEPSC), electrodes were 
made from borosilicate glass capillary tubing (1 – 2 μm tip diameter) and filled with 
internal patch solution with a final resistance of 3–6 MΩ. A slice was placed in the 
recording chamber and perfused at a rate of 5 – 8 mL/min. Membrane potentials were 
held at −70 mV in voltage-clamp mode. The membrane patch was ruptured by a brief 
period of more negative pressure after making a gigaohm seal, further resulting in a 
whole cell configuration. An MP-285 manipulator was used to move the glass 
electrode (MP-285, Sutter, Novato, CA). Data acquisition was performed with 
Clampex 10.2 software. Frequency and amplitude histograms were established using 
this software. 
Immunofluorescence. Immunofluorescence techniques were modified as reported 
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previously [18]. There were five or six rats in each group. Under sodium pentobarbital 
anesthesia (50mg/kg body weight, i.p.), rats were perfused through the aorta using 
0.01 M phosphate buffered saline (PBS, pH 7.2-7.4, 4°C) 200 mL, followed by 4% 
paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB, pH 7.2-7.4, 4°C) 200-300 
mL. The spinal cords were exposed and the lumbar segments were dissected out, 
post-fixed in 4% PFA at 4°C overnight. Then the spinal cords were removed to a 20% 
sucrose solution in 0.1M PB at 4°C overnight, followed by 30% sucrose solution in 
0.1 M PB. The dissected spinal cord was mounted in optimum cutting temperature 
(OCT) compound, frozen at -20°C. Transverse spinal cord sections (20 µm) were cut 
using a cryotome (LEICA CM1900 UV, Germany) and then preserved in 0.01 M PBS 
containing sodium azide at 4 °C. The sections were washed in 0.01 M PBS three 
times, 3 minutes per time, then incubated with blocking solution containing 10% 
normal fetal bovine serum (Gibco, Australia) and 0.2% Triton X-100 for 1h at room 
temperature. Then the floating tissue sections were incubated in a primary antibody in 
the same solution overnight for approximately 16 h at 4 °C on a rocker. The primary 
antibodies used in this experiment were goat polyclonal IBA-1 (1:400, Abcam, USA) 
and rabbit polyclonal P2X7 (1:100, Abcam, USA).The tissue sections were then 
rinsed in 0.01 M PBS three times, 3 minutes each and incubated for about 1 h at room 
temperature in a dark humidity chamber with one of the following secondary 
antibodies: Alexa Fluor®555-conjugated Donkey anti-Rabbit IgG or Alexa 
Fluor®488-conjugated Donkey anti-Goat IgG (1:400, Abcam, USA). The nucleus was 
stained with Hoechst. The tissue sections were washed three times with 0.01 M PBS 
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for 3 minutes each and then mounted on glass slides, and covered with 50% glycerol 
PBS.  
 
Western blot: Animals were deeply anaesthetized using sodium pentobarbital 
(50mg/kg body weight, i.p.) and decapitated. The lumbar spinal cord segments were 
dissected out immediately on an ice bag. The ipsilateral L5 spinal segments were 
homogenized in a lysis buffer containing protease and phosphate inhibitors. Triton 
X-100 was added in the homogenates to a final concentration of 1%, and the 
homogenates were then incubated on ice for 30 minutes and further separated by 
centrifugation (20,000g× 15 minutes). A BCA Protein Assay (Pierce, USA) was used 
to quantify the protein concentrations. The supernatant was run through a 12% 
SDS-polyacrylamide gel, and then wet electro-transferred to a 0.4μm polyvinylidene 
fluoride (PVDF) membrane. The reaction was blocked with 10% evaporated skimmed 
milk at room temperature for 1 h on a rocker, and then incubated overnight for 
approximately 16 h at 4°C in either rabbit anti-P2X7 (1:1000, Abcam, USA) or p38 
(1:1000, Abcam, USA). Blots were rinsed with 0.01 M PBS three times for 10 
minutes each and incubated in a goat anti-rabbit secondary antibody conjugated with 
HRP (1:1000, Sigma, USA) for about 1 h. The target proteins were tested by an 
enhanced chemiluminescence (ECL) detection system (Pierce, USA). The sample was 
normalized with a monoclonal anti-β-Actin antibody produced in mouse (1:1000, Cell 
Signaling Technology, USA). The specific bands were estimated by molecular size. 
Image J software (NIH, USA) was used to detect the signal intensity. 
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Flow cytometry: Flow cytometry was performed as described previously [19]. 
Briefly, MVs obtained from CSF were fixed with 2% PFA for about 15 min, then 
permeabilized with 0.1% PBS-tween for 20 min. The MVs were isolated by 
differential centrifugation and then stained with IBA-1 conjugated with FITC (Abcam, 
USA) and Annexin V conjugated with APC (Sigma, USA) according to the 
manufacture’s protocol. Thereafter, the MVs were washed with pre-chilled PBS. Then 
MVs were isolated through differential centrifugation as described above. 
Re-suspended with PBS and then analyzed using flow cytometry and Kaluza flow 
cytometry analysis software (Beckman Coulter). 
 
ELISA: The type and amount of inflammatory factors in the MVs were estimated 
using an ELISA kit (R&D Systems, USA). The MVs obtained from the microglia cell 
medium were homogenized using a lysis buffer including protease inhibitor [17]. 
Then the protein concentrations were detected using a BCA Protein Assay Kit (Pierce, 
USA). ELISA was performed and the standard curve was depicted according to the 
manufacturer’s protocol. 
 
Electron microscopy: The MVs were fixed with 2.5% glutaraldehyde for about 30 
minutes, re-suspended, and absorbed to a 400 mesh copper screen until the surface 
became desiccated. MVs were subjected to negative staining with 1.9% 
methylcellulose and 0.1% uranyl acetate. Then the samples were observed on a 
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scanning electron microscope. 
 
Statistical analysis. Data are expressed as mean ± standard error (SEM). Repeated 
measurement was used for detecting differences in mechanical thresholds, thermal 
latencies and protein contents over time, between control and ligated animals, or 
vehicle and drug-treated animals. To further detect significant effects of time points, 
two-tailed paired student’s t-test was carried out to analyze the differences. ANOVA 
was used followed by Dunnett's post-hoc test. Pearson correlation coefficients were 
computed to detect potential correlations between the pain behavior and the amount of 
MVs following treatment with FTY720. Values of P < 0.05 were considered to be 
statistically significant. 
 
Results:  
Spinal nerve ligation induces microvesicle shedding from microglia  
In order to understand the changes that occur in microglia in neuropathic pain, an 
experimental animal model for peripheral neuropathic pain by SNL in rats was used in 
our study. Rapidly appearing (< 1 d) and persistent (> 3 weeks) neuropathic pain was 
observed following SNL [20, 21]. MVs separated from CSF after nerve injury was 
examined by negative staining electron microscopy (EM), which revealed the 
presence of MVs with different sizes (>100nm diameter) and shapes (Fig. 1a-c). The 
size of the MVs was slightly larger on day 7 than on day 3 or day 14.  
IBA1 is specifically expressed in microglia, and its upregulation is often considered 
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as a marker of ‘activated microglia’ [22-24]. Therefore, it is possible to use IBA1 to 
detect MVs derived from microglia. The spinal cord slices were stained with IBA1 
and Hoechst. Compared to the sham group, the number of MVs around microglia in 
the dorsal horn was significantly elevated (Fig.1d-i). In addition, the number of shed 
MVs in CSF was evaluated by flow cytometry analysis following IBA and Annexin V 
double-labeling. Microvesicles shed from microglia in CSF were statistically 
significantly increased, especially on the seventh day after SNL (Fig. 2a and b). 
 
Microvesicles are involved in neuropathic pain induced by spinal nerve ligation 
in rat 
FTY720, the first approved oral multiple sclerosis (MS) drug, has been shown to 
significantly reduce the amount of MVs in the CSF of mice with 
experimental autoimmune encephalomyelitis, an animal model of MS [25], so we 
investigated the effect of FTY720 on MVs. Before SNL, no differences in PWT and 
PWL were observed among the control group (Control), sham group (Sham), and 
SNL group (SNL) (Fig. 3a and b). Both the PWT with the strength of the Von Frey 
monofilament stimulation and the PWL to thermal stimulation significantly decreased 
following SNL. After injection of MVs into the naive rat, the PWT and PWL were 
significantly reduced at the beginning of post-injection period (Fig. 3c and d). With 
increasing time, the PWT reached the same level as the PBS group, becoming not 
significantly different. However, a significant difference was still present in the PWL 
after a post-injection period of 6 h. In contrast, we observed a significant elevation of 
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the PWT from 30 min to 2 h and a remarkable increase of the PWL from 30 min to 3 
h after injection of FTY720 into rats following SNL for 7 days, both of which slowly 
declined (Fig. 3e and f). We next examined the number of MVs in the CSF of rats at 
3h and 6h after FTY720 injection. As shown in Fig. 4, FTY720 significantly 
decreased the number of MVs in CSF. Moreover, the number of MVs was lowest at 
3h after FTY720 injection, and began to increase at 6h (Fig. 4). This result was 
consistent with the behavioral results (Fig. 3e and f). All the above data indicate that 
MVs directly participate in the pathology of neuropathic pain induced by SNL in rats. 
 
The P2X7-p38 pathway is involved in the production of microvesicles in rats 
following spinal nerve ligation  
It was thought that the P2X7-p38 pathway was involved in the shedding of MVs [12], 
and we hypothesized that the pathway was also involved in the shedding of MVs 
involved in neuropathic pain induced by SNL. To test our hypothesis, tissue lysates 
following SNL were investigated using western blot analysis. We observed by western 
blotting that SNL induced a significant increase of P2X7 receptors and p38, both of 
which reached a peak at day 7 and maintained this high level at day 14 (Fig. 5a and b). 
Double immunofluorescence indicated that most MVs shed from the microglia were 
P2X7 receptor positive, and the number of MVs positive for P2X7 receptors and 
IBA1 increased from days 3-7 of neuropathic pain development (Fig. 5c). We then 
inhibited the expression of P2X7 receptors by intrathecal injection of P2X7 siRNA 
lentivirus. P2X7 siRNA significantly decreased P2X7 receptor expression levels in 
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the ipsilateral spinal cord (Fig. 6a) and raised the threshold of mechanical allodynia 
and thermal hyperalgesia (Fig. 6b and c). Moreover, intrathecal injection of P2X7 
siRNA observably decreased the number of MVs in CSF extracted on day 7 after SNL 
(Fig. 6d-f). Thus these results suggest that the P2X7-p38 pathway is involved in the 
shedding of MVs induced by SNL. 
 
 
Hyperalgesia induced by microvesicles is mediated by IL-1β. 
It has been demonstrated that P2X7 receptors are predominantly localized on the cell 
membrane of immune cells and glia, where they mediate pro-inflammatory cytokine 
IL-1β release [17, 26]. IL-1β is produced and secreted in pathological conditions, 
associated with increased pain and hyperalgesia [27]. We hypothesized that IL-1β 
mediated the painful action of MVs shed from microglia. To confirm our hypothesis, 
N9 cells were stimulated with BzATP. After exposure to BzATP, the number of 
shedding MVs on the surface of N9 microglia increased significantly (Fig. 7a and b). 
Moreover, the presence of proinflammatory cytokines in MVs was detected. As 
shown in Fig. 7c, IL-1β levels were significantly increased after stimulation with 
BzATP, whereas TNF-α and IL-6 levels did not alter (Fig. 7c). To test whether IL-1β 
contributes to the algogenic effect of MVs, we transfected Lenti-scrambled shRNA or 
Lenti-IL-1β shRNA into N9 cells, and then stimulated them with BzATP. Compared 
to Lenti-scrambled shRNA, treatment with Lenti-IL-1β shRNA significantly 
decreased IL-1β levels in MVs (Fig. 7d). MVs from N9 cells pre-treated with 
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Lenti-scrambled shRNA or Lenti-IL-1β shRNA were intrathecally injected into naive 
rats, and PWT and PWL were determined to evaluate pain behavior. Compared to the 
Lenti-scrambled shRNA group, both PWT and PWL were significantly increased in 
the Lenti-IL-1β shRNA group (Fig. 7e and f). This indicated that IL-1β played an 
important role in the algogenic effect of MVs.  
 
Microglia-derived MVs enhance excitatory neurotransmission 
Given the fact that inflammatory mediators may affect glutamate transmission [28, 
29], we explored the effect of MVs on the modulation of neurotransmission in order 
to further understand the functional role of MVs in the interaction between microglia 
and neurons. 
To evaluate the effect of microglia-derived MVs on neurotransmission, we examined 
sEPSC in the SNL 7-day rat and sham rat, before or after exposure to MVs produced 
from N9 microglia. The MVs were administrated at 5×104/mL. Exposure to MVs 
induced significant increases in sEPSC frequency and amplitude in both groups. 
Compared to the sham group, the spinal cord slices of SNL 7d rats had a smaller 
increase in sEPSC amplitude (Fig. 8b and e). However, MVs increased the frequency 
of sEPSC by more than two-fold in the spinal cord slices from SNL versus sham rats 
(Fig. 8c and f). This suggested that the spinal cord from SNL rats were more sensitive 
to MV stimulation than those from sham rats. These results indicate that MVs shed 
from microglia generated a positive effect on neurotransmission in the development 
of neuropathic pain. 
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Discussion: 
MVs are small shed vesicles (0.1-1μm) which bud directly from the plasma 
membrane, and are released into the extracellular environment upon cell activation 
[30]. However, the majority of studies have focused on exosomes rather than MVs 
shed from the cell surface of multiple cells originating from the brain. There is some 
evidence for the shedding of MVs from a neuronal origin [25, 31]. MVs shed from the 
cell surface of microglia has attracted interest as microglia, the immune cells of the 
nervous system, provide the first line of defense during brain injury. Although a study 
by Gosselin showed that spinal astrocytic activation induced by spared nerve injury 
(SNI) increased the release of EAAT-1 and EAAT-2 from MVs [32], the study did 
not investigate the relationship between MVs and neuropathic pain. 
In our studies, we examined the population and morphology of MVs in the CSF and 
spinal cord of rats. We found that a fraction of large MVs (> 100 nm) were pelleted 
from rat CSF by differential centrifugation (Fig. 1), agreeing with previous findings 
that microglia are able to produce MVs in vivo [25]. In addition, a statistically 
significant increased release of MVs was observed at day 7 following SNL. The 
results suggested that the number of MVs shed from the cell surface of microglia 
increased in a time-dependent manner following SNL, and reached its peak at day 7  
(Fig. 2). This phenomenon suggested that MVs might promote the onset of 
neuropathic pain induced by nerve injury. In previous studies, an early and transient 
increase in the number of microglia induced by peripheral nerve injury was also 
observed. Peripheral nerve injury increased the number of dorsal horn microglia by 
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two to four fold [33-35]. The increase in microglia was demonstrated to be associated 
with proliferation of preexisting cells, as shown by proliferation markers [36-38]. The 
proliferation activity of microglia was shown to reach a peak around 2 days after 
nerve injury and then declined to basal levels [36]. The microglial cell cycle might be 
critical for the changes in MVs.  
Neuropathic pain has been thought to be a chronic pain condition that occurs after 
nerve damage. Accumulating evidence from studies of animal models of neuropathic 
pain indicates that neuropathic pain involves aberrant excitability of the nervous 
system [39-41]. There is evidence that changes occur in neurons as well as spinal 
microglia, the immune cells of the CNS [3, 4, 42]. After peripheral nerve injured by 
SNL, microglia change phenotype to the activated form, following the altered 
expression of diverse molecules, evoking a series of cellular responses involving the 
secretion of proinflammatory factors. In order to further verify the role of MV 
shedding from microglia in neuropathic pain, behavioral tests for mechanical 
allodynia and thermal hyperalgesia were carried out. Following SNL, the sensitivities 
for mechanical allodynia and thermal hyperalgesia were significantly increased with 
withdrawal threshold and withdrawal latency times reducing in a time-dependent 
manner (Fig. 3a and b). In addition, the action of MVs was demonstrated to stimulate 
neuropathic pain by intrathecal administration of concentrated MVs (Fig. 3c and d). 
Moreover, intrathecal injection of FTY720 remarkedly alleviated neuropathic pain 
induced by SNL (Fig. 3e and f), and decreased the number of IBA1+ MVs in CSF (Fig. 
4). These results strongly support our hypothesis that MVs from microglia have a key 
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role in the response to neuropathic pain. 
A correlation of microglia activation with the development of pain hypersensitivity 
has also been elucidated in other nerve injury models. Several microglia-specific 
molecules and signaling pathways have been identified in the development and 
maintenance of neuropathic pain. There is growing evidence that purines and their 
receptors are potential regulators of microglial function. It has also been reported that 
several purinoceptors are expressed in microglia, including P2X4, P2X7, P2Y6 and 
P2Y12 receptors [39]. Of these receptors, the P2X7 receptor is an ATP-gated ion 
channel, highly expressed in immune cells and microglia, where it modulates the 
release of inflammatory cytokines, such as IL-1β and IL-18 [30]. Studies have shown 
that the P2X7-p38 pathway mediates the release of MVs from microglia [12]. The 
P2X7-dependent blebbing is preceded by an alteration of the trans bilayer lipid 
distribution and requires p38 MAP kinase activation [43, 44]. Our results indicated 
that, following SNL, P2X7 receptors and p38 were upregulated in a time-dependent 
manner (Fig. 5a and b). Furthermore, immunofluorescence studies of microglia after 
nerve injury confirmed that P2X7 receptors on microglia significantly increased 
following SNL (Fig. 5c). Intrathecal injection of P2X7 siRNA decreased P2X7 
receptor expression in spinal cord and alleviated neuropathic pain after SNL (Fig. 
6a-c). Interestingly, P2X7 siRNA significantly decreased the number of IBA1+ MVs, 
which was consistent with the behavioral results (Fig. 6). This implied that the 
P2X7-p38 signaling pathway was involved in the mechanism mediating the secretion 
of MVs from reactive microglial cells. 
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MVs have been proposed to mediate IL-1β release from microglia [12]. Upon 
stimulation of BzATP, N9 microglia cells were induced to release MVs (Fig. 7). The 
MVs obtained from the microglia cell medium were detected by ELISA and it was 
found that the level of IL-1β increased significantly, but that of TNF-α and IL-6 
exhibited no significant alteration (Fig. 7c). The change in IL-1β was consistent with 
previous studies, that IL-1β was packaged in the bleb of MVs and secreted through 
the activation of P2X7 receptors [12, 45]. However, the other two cytokines, TNF-α 
and IL-6, displayed no distinct changes. It was reported that various P2X7 receptor 
antagonists blocked the P2X7-dependent release of IL-6, but surprisingly had no 
effect on BzATP-induced release of TNF-α in cultured microglia [46]. In addition, the 
IL-1β levels in concentrated MVs, induced by BzATP, reduced promptly when N9 
microglial cells were transfected with IL-1β shRNA lentivirus (Fig. 7d). Subsequently, 
mechanical allodynia and thermal hyperalgesia were investigated by intrathecal 
administration of MVs concentrated from N9 microglial cells transfected with 
Lenti-shRNA-IL-1β. As shown in Fig. 7, intrathecal injection of MVs from 
Lenti-shRNA-IL-1β transfected N9 microglia, increased both the withdrawal 
threshold and withdrawal latency (Fig. 7e and f). This indicated that the algogenic 
effect of microglia-derived MVs was mediated, at least partly, by IL-1β. This is in 
agreement with previous reports that IL-1β acts as a mediator of supraspinal circuits 
of pain in neuropathic conditions [47-49]. 
Excitatory postsynaptic currents (EPSC) are closely related to pain [50]. Activation of 
low-threshold afferent fibres only generates typical AMPA-receptor-mediated EPSCs, 
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however, high-intensity single-shock stimulation of primary afferent sensory fibres 
produces fast, kainate-receptor-mediated EPSCs in the superficial dorsal horn of the 
spinal cord, indicating that kainate receptors may be restricted to high-threshold 
nociceptive and thermoreceptive primary afferent fibres [50]. In our study, we also 
observed that the MVs derived from microglia enhanced the frequency and amplitude 
of sEPSC within 1 minute after treatment with MVs (Fig. 8), as seen in a previous 
study [51]. However, mechanical and thermal hypersensitivities were induced by 
MVs from 1h but not at 30 min after their intrathecal administration (Fig. 3c and d). 
This may be because painful behavior mediated by MVs was the result of the 
accumulation of EPSCs. Based on our results, MVs shed from the surface of 
microglia contributed to the release of the inflammatory cytokine IL-1β. The effect of 
IL-1β may be involved in the interaction of macrophages and neurons. However, the 
IL-1β may also elicit an increase in the metabolism of sphingolipids in neuronal cells, 
resulting in excitatory neurotransmitter release [30]. Our investigation has provided 
preliminary evidence that MVs involved in neuropathic pain also regulate the 
frequency and amplitude of sEPSC. This suggests another possible pathway by which 
microglia have an effect on neuronal activity. 
In conclusion, we have demonstrated that MVs can be shed from the surface of 
microglia involved in neuropathic pain induced by SNL. The released MVs enhance 
the sensitivity of mechanical allodynia and thermal hyperalgesia induced by SNL, 
with a significant decrease in the withdrawal threshold and withdrawal latency time. 
In addition, the pivotal role of the P2X7-p38 pathway has been demonstrated in the 
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bleb of MVs in the neuropathic model. Furthermore, released IL-1β packaged in the 
MVs has been illustrated to have a positive effect on neuropathic pain. Thus targeting 
the P2X7-p38 pathway involved in the shedding of MVs equipped with IL-1β may 
provide a novel therapeutic approach for the treatment of neuropathic pain. 
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Figure legends and Figures: 
Fig. 1 The existence of microvesicles (MVs) in the cerebrospinal fluid (CSF) and 
dorsal horn of spinal cord of rats. a-c MVs were isolated from the CSF on different 
days following spinal nerve ligation (SNL) and analyzed by negative staining electron 
microscopy. Electron microscopy showed large vesicles with a morphology that was 
consistent with the characteristics of MVs, including delimitation by a lipid bilayer 
and a diameter larger than 100 nm. Scale bar = 100 nm. d-i Immunofluorescence 
labeling of MVs shed from microglia in the dorsal horn of spinal cord of sham group 
(d, f, and h) and SNL 7 day rat (e, g, and i). MVs derived from microglia were 
analyzed by fluorescence microscopy using the microglia marker IBA-1 (d and e), 
and the nucleus marker Hoechst (f and g). Merged images are shown in the right 
column (h and i). As indicated by arrows, MVs around microglia were stained by 
IBA1without Hochest (n = 4 rats for each group). 
 
Fig. 2 a-e Flow cytometry analysis of microvesicles (MVs) presented in the rat 
cerebrospinal fluid after spinal nerve ligation, directly stained with IBA1 conjugated 
with FITC and Annexin V conjugated with APC. f The quantification of MVs stained 
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with IBA-1 conjugated with FITC in flow cytometry experiments. All data are mean
±SEM. *P < 0.05, **P < 0.01, compared with control group. 1-way ANOVA, 
followed by Bonferroni's post-hoc test was applied (n = 3 rats for each group). 
 
Fig. 3 Time course of changes in paw withdrawal threshold and paw withdrawal 
latency following spinal nerve ligation (SNL) (a and b) or with injection of 104 
microvesicles (MVs) into naive rats (c and d) or 10uL FTY720 (e and f, 1mM) into 
rats following SNL for 7 days. All data points are mean ± SEM. *P< 0.05, compared 
with control group or PBS group; n = 6 rats for each group. Statistical significance 
was determined by repeated measures ANOVA, followed by Student's t test. 
 
Fig. 4 The number of microvesicles (MVs) in cerebrospinal fluid (CSF) decreased 
after FTY720 intrathecal injection on day 7 after SNL. a-c Flow cytometry analysis of 
MVs in CSF after PBS (a) or FTY720 injection 3h (b) or FTY720 injection 6h (c). d 
Quantity of IBA1+ MVs in a-c. All data are mean ± SEM. *P < 0.05, compared with 
PBS group, #P < 0.05; n = 3 rats for each group. Statistical significance was 
determined by 1-way ANOVA, followed by Bonferroni's post-hoc test. 
 
Fig. 5 P2X7 receptors on microglia increased after spinal nerve ligation (SNL). a 
Western blot analysis of P2X7 receptors and p38 in spinal cord after SNL. b The 
quantitative analysis of P2X7 receptors and p38 normalized to β-Actin at different 
times. c Fluorescent images of microglia from spinal cord in rats following SNL, 
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stained for P2X7 receptors (red) and IBA-1 (green). Note the presence of many 
microvesicles at the cell surface positive for both P2X7 receptors and IBA1. All data 
points are mean ± SEM. *P<0.05, significant difference as compared with the sham 
group. 1-way ANOVA, followed by Bonferroni's post-hoc test was applied. n = 4 rats 
for each group. 
 
Fig. 6 Inhibition of P2X7 receptors decreased the number of microvesicles (MVs) 
derived from microglia and alleviated pain after SNL. a P2X7 receptor expression 
level in ipsilateral spinal cord on after intrathecal injection of lenti-P2X7 siRNA or 
lenti-control siRNA. b, c Paw withdrawal threshold to mechanical stimuli (b) and paw 
withdrawal latency to thermal stimuli (c) of rats tested on day 7 after SNL, following 
intrathecal injection of lenti-P2X7 siRNA or lenti-control siRNA. d, e Flow cytometry 
analysis of MVs in cerebrospinal fluid (CSF) acquired after intrathecal injection of 
lenti-control siRNA (d) or lenti-P2X7 siRNA (e). f The quantification of IBA+ MVs in 
100ul CSF. Lenti-control siRNA or lenti-P2X7 siRNA was injected intrathecally 3 
days before SNL, and spinal cord or CSF acquired on day 7 after SNL. All data points 
are mean ± SEM. *P<0.05, compared with BL or control siRNA; #P < 0.05. (n = 6 rats 
for group b and c, n = 3 rats for group a, d, e, f ) 
 
Fig. 7 Hyperalgesia induced by microvesicles (MVs) was mediated, at least partly, by 
IL-1β. a, b Exposure to BzATP induced MV shedding from the N9 cell line (a, control; 
b, BzATP). c Concentration of IL-1β, TNF-α and IL-6 in MVs obtained from the 
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microglia cell medium by ELISA. d Concentration of IL-1β in MVs derived from N9 
cells transfected with Lenti-scrambled shRNA or Lenti-IL-1β shRNA followed by 
stimulation with BzATP. e, f Paw withdrawal threshold to mechanical stimuli (e) and 
paw withdrawal latency to thermal stimuli (f) of rats administered with MVs (104 per 
rat) obtained from N9 cells transfected with Lenti-scrambled shRNA or Lenti-IL-1β 
shRNA. Shedding MVs are indicated by an arrow in b. All data points are mean ± 
SEM. *P<0.05, a significant difference as compared with the control group or the 
lenti-scrambled shRNA group. 1-way ANOVA, followed by Bonferroni's post-hoc 
test (c) or Student's t test (d) or repeated measures ANOVA, followed by Student's t 
test (e and f) was applied. n = 3 rats for group c and d, and n = 6 rats for group e and f. 
 
Fig. 8 Microglia-derived microvesicles (MVs) enhance excitatory neurotransmission. 
Representative recording of spontaneous excitatory postsynaptic current (sEPSC) 
amplitude and frequency in the dorsal horn of the spinal cord of sham rats (a) or 
spinal nerve ligation (SNL) 7 day rats (d) before and during MV treatment. Summary 
of the effect of MVs on the amplitude of sEPSC in sham rats (b) or SNL 7 day rats (e). 
Summary of the effect of MVs on the frequency of sEPSC in sham rats (c) or SNL 7 
day rats (f). Two-tailed paired student’s t-test was applied to analyze the differences, 
with significance assumed at P < 0.05. Error bars are SEM (n = 3 rats for each group). 
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